Oracle (NYSE: ORCL) stock has been resilient in the last 30 days of trading despite investor concerns and the July credit downgrade, and Wall Street analysts believe this strength will only grow.
Specifically, Citi’s (NYSE: C) Tyler Radke issued a note on Wednesday, August 26, in which he reiterated the previous ‘Buy’ rating and the bullish $330 12-month price target – effectively estimating a 101.52% rally from the latest close – but also added an ‘upside 90-day catalyst watch’ on the equity.
According to the institutional expert, Oracle stock is severely dislocated following the earlier sell-offs – ORCL shares are 23.93% down year-to-date (YTD) and fell 4.70% since August 13 despite being up on the monthly chart – and will likely benefit from significant upside revisions on ‘robust’ artificial intelligence (AI) demand.
Analysts predict Oracle stock price in the next 12 months
Elsewhere, Radke’s assessment of the company is overall close to the wider attitude on Wall Street, though his equity price target for the next 12 months is significantly higher than the average.
Indeed, Oracle stock is overall regarded as a ‘Strong Buy,’ with twenty-eight positive, four ‘Hold,’ and no ‘Sell’ recommendations, and is expected to rally 72.16% to $257.79, per the data Finbold retrieved from the TipRanks analysis platform on Thursday, August 27.
Additionally, all but one August revision positions ORCL shares as a ‘Buy,’ though the majority of forecasts see the equity remaining below $300 in the 12-month timeframe.
Notably, however, even the single ‘Hold’ rating given in the eighth month of 2026 was accompanied by an optimistic $190 price target.
Considering Oracle stock faced the latest closing bell at $148.87, this forecast means that even the ‘Neutral’ analyst Rishi Jaluria of RBC Capital anticipates a 27.63% rally in the coming 52 weeks.
Still, the $400 Street high estimate – provided by Guggenheim analyst John Difucci – was assigned as recently as late July.
Featured image via Shutterstock
